Orgenesis Short Term Investments vs Long Term Investments Analysis
ORGS Stock | USD 0.54 0.01 1.89% |
Orgenesis financial indicator trend analysis is much more than just breaking down Orgenesis prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Orgenesis is a good investment. Please check the relationship between Orgenesis Short Term Investments and its Long Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.
Short Term Investments vs Long Term Investments
Short Term Investments vs Long Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Orgenesis Short Term Investments account and Long Term Investments. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Orgenesis' Short Term Investments and Long Term Investments is -0.37. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Long Term Investments in the same time period over historical financial statements of Orgenesis, assuming nothing else is changed. The correlation between historical values of Orgenesis' Short Term Investments and Long Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Orgenesis are associated (or correlated) with its Long Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Investments has no effect on the direction of Short Term Investments i.e., Orgenesis' Short Term Investments and Long Term Investments go up and down completely randomly.
Correlation Coefficient | -0.37 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Short Term Investments
Short Term Investments is an item under the current assets section of Orgenesis balance sheet. It contains any investments Orgenesis undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Orgenesis can easily liquidate in the marketplace.Long Term Investments
Long Term Investments is an item on the asset side of Orgenesis balance sheet that represents investments Orgenesis intends to hold for over a year. Orgenesis long term investments may include different instruments such as stocks, bonds, real estate and cash.Most indicators from Orgenesis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Orgenesis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.At this time, Orgenesis' Discontinued Operations is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 5.9 M in 2024, whereas Tax Provision is likely to drop (87.2 K) in 2024.
2023 | 2024 (projected) | Reconciled Depreciation | 1.7M | 1.7M | Interest Income | 31.5K | 29.9K |
Orgenesis fundamental ratios Correlations
Click cells to compare fundamentals
Orgenesis Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Orgenesis fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 73.9M | 77.7M | 59.8M | 90.9M | 14.6M | 38.8M | |
Other Current Liab | 6.8M | 2.3M | 2.4M | 4.7M | 4.1M | 7.1M | |
Total Current Liabilities | 17.2M | 16.3M | 15.4M | 15.9M | 16.4M | 11.9M | |
Total Stockholder Equity | 26.1M | 52.6M | 38.5M | 27.6M | (21.0M) | 27.4M | |
Net Debt | (32.0M) | 6.4M | 15.0M | 21.8M | 25.1M | 26.3M | |
Retained Earnings | (65.2M) | (88.3M) | (106.4M) | (121.3M) | (176.6M) | (68.4M) | |
Accounts Payable | 4.6M | 8.6M | 5.2M | 4.4M | 6.6M | 3.7M | |
Cash | 14.6M | 44.9M | 5.5M | 5.3M | 837K | 15.3M | |
Cash And Short Term Investments | 14.6M | 44.9M | 5.5M | 5.3M | 837K | 15.3M | |
Common Stock Shares Outstanding | 21.3M | 24.3M | 25.1M | 29.0M | 33.4M | 35.0M | |
Liabilities And Stockholders Equity | 77.7M | 59.8M | 90.9M | 14.6M | 16.7M | 15.9M | |
Other Stockholder Equity | 669K | 140.1M | 144.7M | 149.1M | 155.6M | 635.6K | |
Total Liab | 47.8M | 25.0M | 21.2M | 31.7M | 35.5M | 25.6M | |
Total Current Assets | 28.1M | 50.1M | 25.8M | 46.3M | 4.1M | 15.1M | |
Non Current Assets Total | 27.6M | 34.1M | 44.6M | 10.5M | 12.0M | 11.4M | |
Other Current Assets | 387K | 1.7M | 1.7M | 4.7M | 3.1M | 367.7K | |
Intangible Assets | 16.6M | 13.0M | 11.8M | 9.7M | 7.4M | 9.9M | |
Other Liab | 2.2M | 387K | 389K | 578K | 2.0M | 2.5M | |
Property Plant And Equipment Net | 4.5M | 11.3M | 25.1M | 1.8M | 2.1M | 2.0M | |
Non Currrent Assets Other | 440K | 821K | 805K | 1.4M | 18K | 708.5K | |
Other Assets | 1.3M | 1.5M | 2.8M | 8.6M | 1.7M | 1.8M | |
Net Receivables | 3.2M | 3.3M | 18.5M | 39.8M | 2.6M | 3.1M | |
Non Current Liabilities Total | 8.7M | 5.8M | 15.7M | 19.1M | 22.0M | 16.6M | |
Inventory | 1.7M | 185K | 118K | 120K | 34K | 1.7M | |
Property Plant And Equipment Gross | 12.5M | 4.5M | 11.3M | 29.1M | 2.4M | 10.1M | |
Property Plant Equipment | 11.9M | 12.5M | 4.3M | 5.1M | 14.3M | 15.0M | |
Short Long Term Debt Total | 4.8M | 12.9M | 11.8M | 20.3M | 22.6M | 4.5M | |
Accumulated Other Comprehensive Income | 1M | 748K | 207K | (270K) | 65K | 1.1M | |
Short Term Debt | 753K | 4.6M | 6.4M | 5.1M | 3.6M | 715.4K | |
Net Tangible Assets | (5.8M) | 30.8M | 18.3M | 9.7M | (6.7M) | (6.3M) | |
Current Deferred Revenue | 751K | 1.3M | 1.6M | 2.2M | 2.5M | 3.6M | |
Short Long Term Debt | 753K | 4.1M | 5.9M | 4.5M | 3.3M | 715.4K | |
Long Term Debt | 2.8M | 7.3M | 4.9M | 13.3M | 19.0M | 2.7M | |
Good Will | 15.3M | 8.7M | 8.4M | 8.2M | 1.2M | 8.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Orgenesis Stock analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Orgenesis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orgenesis. If investors know Orgenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orgenesis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 0.018 | Quarterly Revenue Growth (0.99) | Return On Assets (0.62) | Return On Equity (3.39) |
The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Orgenesis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.